C - Chemistry – Metallurgy – 07 – C
Patent
C - Chemistry, Metallurgy
07
C
C07C 233/43 (2006.01) A61K 31/167 (2006.01) A61P 11/08 (2006.01)
Patent
CA 2525839
The invention provides a novel .beta.2 adrenergic receptor agonist in crystalline salt form. The invention also provides pharmaceutical compositions comprising the novel .beta.2 adrenergic receptor agonist in crystalline salt form, formulations containing the pharmaceutical compositions, methods of using the crystalline salt to treat diseases associated with .beta.2adrenergic receptor activity, and processes useful for preparing such crystalline compounds.
L'invention concerne un agoniste de récepteur .beta.2-adrénergique sous forme de sel cristallin, ainsi que des compositions pharmaceutiques le renfermant, des formulations contenant ces compositions, des procédés relatifs à l'utilisation du sel cristallin pour le traitement de maladies associées à l'activité du récepteur en question, et des procédés utiles pour l'élaboration de tels composés cristallins.
Hubbard Cristin
Stergiades Ioanna
Yost Edward
Zhang Weijiang
Theravance Inc.
Torys Llp
LandOfFree
Crystalline form of .beta.2 adrenergic receptor agonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystalline form of .beta.2 adrenergic receptor agonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline form of .beta.2 adrenergic receptor agonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1982559